Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac amyloidosis: heterogenous pathogenic backgrounds.

Shu-ichi Ikeda1

  • 1Third Department of Medicine, Shinshu University School of Medicine, Matsumoto.

Internal Medicine (Tokyo, Japan)
|January 14, 2005
PubMed
Summary

Cardiac amyloidosis, a severe heart condition, arises from systemic amyloidosis, including immunoglobulin light chain and transthyretin-related types. Early diagnosis and understanding cardiac involvement are crucial for managing this fatal disorder.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): Estimation of pathological lesion stage from brain images.

Journal of the neurological sciences·2024
Same author

A Long-Term Observation on the Possible Adverse Effects in Japanese Adolescent Girls after Human Papillomavirus Vaccination.

Vaccines·2021
Same author

Pathologic basis of the preferential thinning of thecorpus callosum in adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP).

eNeurologicalSci·2021
Same author

A 67-Year-Old Man with Leg Weakness and Hypertrophic Cardiomyopathy.

Brain pathology (Zurich, Switzerland)·2020
Same author

Sjögren syndrome-related plasma cell disorder and multifocal nodular AL amyloidosis: clinical picture and pathological findings.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2019
Same author

Tafamidis dramatically improved severe proteinuria in a patient with TTR V30M hereditary ATTR amyloidosis.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2019

Area of Science:

  • Cardiology
  • Genetics
  • Pathology

Background:

  • Cardiac amyloidosis is a fatal consequence of systemic amyloidosis.
  • Common causes include immunoglobulin light chain (AL) amyloidosis and transthyretin-related hereditary amyloidosis (ATTR).
  • Senile systemic amyloidosis is increasingly recognized as a cause of cardiac dysfunction in the elderly.

Purpose of the Study:

  • To review the diverse causes and clinical presentations of cardiac amyloidosis.
  • To highlight diagnostic modalities for identifying cardiac amyloid deposition.
  • To discuss the implications of cardiac involvement on prognosis and treatment.

Main Methods:

  • Review of literature on systemic amyloidosis and cardiac involvement.
  • Discussion of diagnostic tools: echocardiography, technetium-99m-pyrophosphate scintigraphy.

Related Experiment Videos

  • Emphasis on tissue immunohistochemistry, serum/urine protein analysis, and DNA sequencing for amyloid typing.

    • Main Results:

    • Transthyretin-related hereditary amyloidosis presents with variable clinical pictures due to numerous gene mutations.
    • Cardiac amyloidosis can occur in patients of diverse ancestry.
    • Diagnostic imaging and biochemical analyses are key to identifying amyloid types.

    Conclusions:

    • Systemic amyloidosis leading to cardiac involvement is treatable.
    • Prognosis is significantly influenced by the extent of cardiac amyloid deposition.
    • Accurate diagnosis of amyloid type and cardiac involvement is essential for effective management.